Public Policy Resources

Share

As a recognized expert in cancer health policy, ACS CAN develops reports, white papers, testimony, fact sheets, regulatory comment letters and public policy on a wide range of issues related to preventing cancer and improving the health care system for persons with cancer and survivors.  We encourage you to use this resource to learn more about our issue priorities and policy work. If you can't find something you need, you may contact us by using our contact form and selecting Policy Resources from the drop-down menu.

Search for Resources

FILTER BY:

Photo of female cancer patient

Patient Quality of Life

ACS CAN advocates for policies that improve the lives of cancer patients by making treatment of their pain and other symptoms and coordination of their care standard protocol throughout their treatment for cancer, starting at the point of diagnosis.
 

Featured Resources

 

The Pain & Policy Studies Group (PPSG) at the University of Wisconsin, the American Cancer Society and the American Cancer Society Cancer Action Network (ACS CAN) have released a report grading states on their enactment of balanced policies to enhance the delivery of effective pain management

This scorecard evaluates balance between needed access to pain medication for cancer patients and efforts to reduce misuse and abuse of pain medications.

Our brochure helps educate cancer patients and their caregivers about palliative care and its benefits. From where you can find it to how you receive it, the brochure can help cancer patients access this important level of medical care.

Photo of ACS CAN Volunteers at Advocacy Event to Support Cancer Research Funding

Research, Funding and Drug Development

Improvements in outcomes for cancer patients require continued research and innovation.  ACS CAN advocates for robust federal funding for cancer research, as well as research and drug approval policies that accelerate the development of new treatments while still ensuring patient safety.

Expanded access inovolves accessing unapproved therapies outside of clinical trials.  This process has been in existience since the late 1980s, and currently there have been calls to change the process.

Molecular tests are critical to safe, effective care for cancer patients, yet the oversight system for laboratory developed tests is in need of updating.  This letter, co-signed by 33 organizations, request that Congress act to ensure appropriate diagnostic oversight. 

ACS CAN supports the proposal to allow public databases to serve as a source of evidence to support regulatory demonstration of clinical validity of diagnostic tests.

Photo of ACS CAN Volunteers participating in health care reform Lobby Day event

Access to Health Care

ACS CAN advocates for policies that provide access to treatments and services people with cancer need for their care - including those who may be newly diagnosed, in active treatment and cancer survivors.

Numerous provisions of H.R. 1628, the American Health Care Act (AHCA), would adversely impact access to adequate and affordable health insurance coverage for cancer patients and survivors.

Hispanic/Latina women have the highest incidence of cervical cancer compared to other races/ethnicities. In 2015 approximately 2,000 Hispanic/Latina women in the U.S. were expected to be diagnosed with cervical cancer and 600 were expected to die from the disease. This factsheet discusses the cervical cancer health disparities found in Hispanic/Latina women and way to reduce this disparity.

 

On April 25, 2017, the text of an amendment to the American Health Care Act (AHCA) to be offered by Representative MacArthur (R-NJ) was released.  The amendment could undo several key protections that are critical for cancer patients and survivors – including the prohibition on pre-existing condition exclusions.

Photo of Making Strides Against Breast Cancer Event Participant

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

ACS CAN provided comments in response to a U.S. Food and Drug Administration (FDA) request for information on the use of the term “healthy” on food labels.

ACS CAN supports updating the criteria for "healthy" to be consistent with current research and dietary guidance.  If defined appropriately, “healthy” can be a tool to help consumers identify choices that support long-term health, including reduced cancer risk. 

This factsheet discusses risk factors for breast cancer and the importance of screening in the US.

ACS CAN provided comments to the U.S. Department of Agriculture on a proposed rule to update the Nutrition Facts Label for meat and poultry.